Literature DB >> 29618010

Hypoglycemic Exposure and Risk of Asymptomatic Hypoglycemia in Type 1 Diabetes Assessed by Continuous Glucose Monitoring.

Marie Moth Henriksen1, Henrik Ullits Andersen2, Birger Thorsteinsson1,3, Ulrik Pedersen-Bjergaard1,3.   

Abstract

Context: Recurrent hypoglycemia promotes impaired awareness, resulting in an increased risk for asymptomatic hypoglycemia. However, there are no firm data on the frequency of hypoglycemia in daily life needed to initiate this vicious cycle or the role of asymptomatic hypoglycemia. Objective: To explore the association between hypoglycemic exposure and proportion of asymptomatic hypoglycemia and relation to risk for severe hypoglycemia. Design: Prospective observational trial. Setting: Outpatient clinic. Patients: One hundred fifty-three unselected patients with type 1 diabetes mellitus (T1D). Intervention: Six days of blinded continuous glucose monitoring and recording of hypoglycemia symptoms. Main Outcome Measure: Proportion of asymptomatic hypoglycemic events (glucose level ≤70 mg/dL).
Results: Patients were grouped by the number of hypoglycemic events during the recording period (group 1: one event; group 2: two to three events; group 3: four to six events; group 4: seven or more events), and fractions of asymptomatic events were calculated. Across the four groups, the fraction of asymptomatic hypoglycemia increased: 57% in group 1, 61% in group 2, 65% in group 3, and 80% in group 4 (P < 0.001). Higher fraction of asymptomatic hypoglycemia was positively associated with risk for severe hypoglycemia (incidence rate ratio, 1.3; 95% confidence interval, 1.1 to 1.5; P = 0.003). Group 4 consisted of patients characterized by classic risk factors of severe hypoglycemia (longer duration of diabetes, lower hemoglobin A1c, and more frequent impaired awareness of hypoglycemia). Conclusions: Patients with T1D with hypoglycemic rates corresponding to daily exposure had an increased fraction of asymptomatic events, which was positively associated with risk for severe hypoglycemia; therefore, such patients deserve particular attention in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29618010     DOI: 10.1210/jc.2018-00142

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Richard I G Holt; J Hans DeVries; Amy Hess-Fischl; Irl B Hirsch; M Sue Kirkman; Tomasz Klupa; Barbara Ludwig; Kirsten Nørgaard; Jeremy Pettus; Eric Renard; Jay S Skyler; Frank J Snoek; Ruth S Weinstock; Anne L Peters
Journal:  Diabetologia       Date:  2021-12       Impact factor: 10.122

Review 2.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

3.  Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes.

Authors:  Marie M Henriksen; Henrik U Andersen; Birger Thorsteinsson; Ulrik Pedersen-Bjergaard
Journal:  Diabetologia       Date:  2021-01-14       Impact factor: 10.122

4.  Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report.

Authors:  Cyril P Landstra; Axel Andres; Mikael Chetboun; Caterina Conte; Yvonne Kelly; Thierry Berney; Eelco J P de Koning; Lorenzo Piemonti; Peter G Stock; François Pattou; Marie-Christine Vantyghem; Melena D Bellin; Michael R Rickels
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 6.134

5.  The Association of Hypoglycemia Assessed by Continuous Glucose Monitoring With Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes.

Authors:  Wei Wei; Shi Zhao; Sha-Li Fu; Lan Yi; Hong Mao; Qin Tan; Pan Xu; Guo-Liang Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

6.  Exposure to recurrent hypoglycemia alters hippocampal metabolism in treated streptozotocin-induced diabetic rats.

Authors:  Neelesh Dewan; Vibha Shukla; Ashish K Rehni; Kevin B Koronowski; Kyle D Klingbeil; Holly Stradecki-Cohan; Timothy J Garrett; Tatjana Rundek; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  CNS Neurosci Ther       Date:  2019-07-07       Impact factor: 5.243

7.  Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-12-12

8.  Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo-RESOLVE) project.

Authors:  B E de Galan; R J McCrimmon; M Ibberson; S R Heller; P Choudhary; F Pouwer; J Speight; J Carlton; T R Pieber; M Rosilio; C J Tack; M Müllenborn
Journal:  Diabet Med       Date:  2020-02-05       Impact factor: 4.359

Review 9.  Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.

Authors:  I Banerjee; M Salomon-Estebanez; P Shah; J Nicholson; K E Cosgrove; M J Dunne
Journal:  Diabet Med       Date:  2018-10-08       Impact factor: 4.359

Review 10.  Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic.

Authors:  E G Wilmot; A Lumb; P Hammond; H R Murphy; E Scott; F W Gibb; J Platts; P Choudhary
Journal:  Diabet Med       Date:  2020-11-16       Impact factor: 4.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.